Abstract
The body’s resistance to the actions of insulin (type II diabetes defect) results in compensatory increased production and secretion by the pancreas and leads to hyperinsulinemia in order to maintain euglycemia. When insulin secretion cannot be increased adequately (type I diabetes defect) to overcome insulin resistance in maintaining glucose homeostasis, hyperglycemia and glucose intolerance ensues. Insulin resistance and glucose intolerance has been well recognized in patients with advanced chronic kidney diseases (CKD). The etiology may involve uremic toxins from protein catabolism, vitamin D deficiency, metabolic acidosis, anemia, poor physical fitness, inflammation, and cachexia. Glucose and insulin abnormalities in nondiabetic CKD patients are implicated in the pathogenesis of hyperlipidemia and may represent important risk factors for accelerated atherosclerosis in these patients. Insulin secretion inadequacy has been associated with growth retardation in adolescents with CKD. Normal adolescents demonstrate an increase in insulin secretion as they go into puberty. It seems that the puberty growth spurt in adolescents both with normal health and renal failure may require increased insulin secretion as one of its hormonal requirements. Finally, insulin resistance has been associated with CKD. Whether insulin resistance is an antecedent of CKD or a consequence of impaired kidney function has been a subject of debate. The goal of this review was to provide an update of the literature on insulin pathophysiology in CKD, current understanding of its mechanisms, and epidemiological association of insulin resistance and CKD.
Similar content being viewed by others
References
DeFronzo RA, Alvestrand A, Smith D, Hendler R, Wahren J (1981) Insulin resistance in uremia. J Clin Invest 67:563–568
Mak RH, Haycock GB, Chantler C (1983) Glucose intolerance in children with chronic renal failure. Kidney Int 24(Suppl 15):S22–S26
Mak RH, DeFronzo RA (1992) Glucose and insulin metabolism in uremia. Nephron 61:377–382
Wahba I, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2:550–562
Rabkin R, Simon NM, Steiner S, Colwell JA (1970) Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 282:182–187
Mondon CE, Dolkas CB, Reaven GM (1978) Effect of acute uremia on insulin removal by the isolated perfused rat liver and muscle. Metabolism 27:133–142
Friedman JE, Dohm GL, Elton CW, Rovira A, Chen JJ, Leggett-Frazier N, Atkinson SM, Thomas FT, Long SD, Caro JF (1991) Muscle insulin resistance in uremic humans: glucose transport, glucose transporters and insulin receptors. Am J Physiol 261:E87–E94
Alvestrand A (1997) Carbohydrate and insulin metabolism in renal failure. Kidney Int 52(Suppl 62):S48–S52
Contreras I, Caro JF, Aveledo L, Diaz K, Durrego P, Weisinger JR (1992) In chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase. Nephron 61:77–81
Bailey JL, Zheng B, Hu Z, Prive SR, Mitch WE (2006) Chronic kidney disease causes defects in signaling through insulin receptor substrate/phosphoinositol 3-kinase/Akt pathway: Implications for muscle wasting. J Am Soc Nephrol 17:1388–1394
McCaleb ML, Izzo MS, Lockwood DH (1985) Characterization and partial purification of a factor from uremic serum that induces insulin resistance. J Clin Invest 75:391–396
Dzuric R, Spustova V, Lajdova I (1993) Inhibition of glucose utilization in isolated rat soleus muscle by pseudouridine: Implications for renal failure. Nephron 65:108–110
Mak RH (1996) Insulin resistance in uremia: Effect of dialysis modality. Pediatr Res 40:304–308
Mak RH, Turner C, Thompson T, Haycock GB, Chantler C (1986) The effect of dietary protein restriction and amino acid/keto acid supplements on glucose metabolism in uremic children. J Clin Endocrinol Metabol 63:985–989
Rigalleau V, Combe C, Blanche V, Aubertin J, Apacicio M, Gin H (1997) Low protein diet in uremia. Effect of glucose metabolism and energy production rate. Kidney Int 51:1222–1227
Mak RH (1998) 1,25 vitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53:1353–1357
Mak RH (1998) Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54:603–607
Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28:1228–1230
Chonchol M, Scragg R (2007) 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71:134–139
Eidmak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strangaard S (1995) Insulin resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38:565–572
Goldberg A, Hagberg J, Delmez J, Haynes ME, Harter HR (1989) The metabolic effects of exercise training in hemodialysis patients. Kidney Int 18:754–761
Mak RH (1996) Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 270:F839–F894
Mak RH (1996) The effect of erythropoietin on insulin, amino acid and lipid metabolism in uremia. J Pediatr 129:97–104
Mak RH (1998) Metabolic effects of erythropoietin in uremic patients on peritoneal dialysis. Pediatr Nephrol 12:660–665
Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA (2007) Insulin resistance is associated with skeletal muscle breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71:146–152
Church JM, Hill GL (1988) Impaired glucose metabolism in surgical patients improved by intravenous nutrition: assessment by euglycemic-hyperinsulinemic clamp. Metabolism 37:505–509
Mak RH Cheung W, Cone R, Marks DL (2005) Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol 20:427–431
Mak RH, Cheung W, Cone R, Marks DL (2006) Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol 21:1807–1814
Lai HL, Kartal J, Mitsnefes M (2007) Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-alpha. Pediatr Nephrol DOI 10.1007/s00467-007-0533-z
Mak RH, Bettinelli A, Turner C, Haycock GB, Chantler C (1985) The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 60:229–233
Mak RH, Turner C, Haycock GB, Chantler C (1983) Secondary hyperparathyroidism and glucose intolerance in children with uremia. Kidney Int 24(Suppl 16):S128–S133
Akmal M, Massry SG, Goldstein D, DeFronzo RA (1985) The role of parathyroid hormone in the glucose intolerance in uremia. J Clin Invest 75:1037–1044
Mak RH (1992) 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 41:1049–1054
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
Horgaard A, Thayssen TH (1929) Clinical investigation into the effect of the intravenous injection of insulin. Acta Med Scand 72:92–95
Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–48
Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790–800
Hosker JP, Matthews DR, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:401–411
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410
Maddux BA, Chan A, Mandarino LJ, Goldfine ID (2006) IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 29:1535–1537
Reaven G (1997) The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 30:928–931
Liu Z (2007) The renin-angiotensin system and insulin resistance. Curr Diab Rep 7:34–42
Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME (2005) Why blockade of the rennin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 23:463–473
Klahr S, Morrissey JJ (2000) The role of vasoactive compounds, growth factor and cytokines in the progression of renal disease. Kidney Int 75(Suppl):S7–S14
Chan MK, Varghese Z, Moorhead JF (1981) Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 19:625–637
Saland JM, Ginsberg HN (2007) Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 22:1095–1112
Kaysen GA (2006) Metabolic syndrome and renal failure. Panminerva Med 48:151–164
Fadini GP, Pauletto P, Avogaro A, Rattazzi M (2007) The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis 193:241–244
Chen NX, Duan D, O’Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21:3435–3442.
Olesen P, Nguyen K, Wogensen L, Ledet T, Rasmussen LM (2007) Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol 292:H1058–H1064
Baxter RC, Turtle JR (1978) Regulation of growth hormone receptors by insulin. Biochem Biophy Res Com 84:350–357
Daughaday WH, Philips LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinol 98:1214–1219
Maes M, Underwood LE, Ketelslegers JM (1986) Low serum somatomedin-C in insulin-dependent diabetes: evidence for a postreceptor mechanism. Endocrinol 118:377–382
Cotterill AM, Cowell CT, Silink M (1989) Insulin and variation in glucose levels modify the secretion rates of the growth hormone-dependent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell-line Hep G2. J Endocrinol 12:R17–R20
Dunger DB, Cheetham TD (1996) Growth hormone-insulin-like growth factor-I axis in insulin-dependent diabetes mellitus. Horm Res 46:2–6
Mak RH (1995) Insulin secretion and growth in uremia. Pediatr Res 38:379–383
Mak RH (1998) Insulin, branched-chain amino acids and growth failure in uremia. Pediatr Nephrol 12:637–642
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140:167–174
Peralta CA, Kurella M, Lo JC, Chertow GM (2006) The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 15:361–365
Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Am Soc Nephrol 16:2134–2140
Palaniappan L, Carnethon M, Fortmann SP (2003) Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 16:952–958
Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A (2004) Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 22:1991–1998
Mule G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiovì R, Mezzatesta G, Andronico G, Cerasola G (2005) Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 257:503–513
Godfrey KM, Barker DJ (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71:1344S–1352S
Hinchliffe SA, Lynch MR, Sergent PH, Howard CV, Van Velzen D (1992) The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 99:296–301
MacDonald MD, Emery JL (1959) The late intrauterine and postnatal development of human renal glomeruli. J Anat 93:331–340
Manalich R, Reyes L, Herrera M, Melendi C, Fundora I (2000) Relationship between weight at birth and the number and size of glomeruli in humans: A histomorphometric study. Kidney Int 58:770–773
Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49:1774–1777
Brenner BM, Chertow GM (1993) Congenital oligonephropathy: An inborn cause of adult hypertension and progressive renal injury? Curr Opin Nephrol Hypertens 2:691–895
Keller G, Zimmer G, Mall, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101–108
Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tisuue. J Clin Invest 112:1785–1788
Engeli S, Sharma AM (2000) Role of adipose tissue for cardiovascular-renal regulation in health and disease. Horm Metab Res 32:485–499
Knight SF, Imig JD (2007) Obesity, insulin resistance and renal function. Microcirculation 14:349–362
Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia and renal injury: mechanism and implications. Am J Nephrol 26:232–244
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a Mid-Career Research Development Award K24 DK59574 and U01 DK-03–012 from the National Institute of Health to RHM.
Rights and permissions
About this article
Cite this article
Mak, R.H. Insulin and its role in chronic kidney disease. Pediatr Nephrol 23, 355–362 (2008). https://doi.org/10.1007/s00467-007-0611-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0611-2